Evaluating the Use of Advance Directives in Intensive Care
Advance Directive Implementation and Scientific Evaluation (ADVISE) Study
This study looks at how having advance directives affects the health outcomes of adults in the intensive care unit at University Hospital Basel.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 2 sites (Aarau and 1 other locations) |
| Trial ID | NCT04348318 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the implementation and impact of advance directives on patient outcomes in the intensive care unit at the University Hospital Basel. By retrospectively extracting data from digital medical records of adult patients admitted between 2011 and 2023, the study will assess the proportion of patients with advance directives and compare their in-hospital outcomes, such as survival and neurological recovery, to those without such directives. Descriptive analyses will be utilized to provide insights into the effectiveness of advance directives in guiding treatment decisions during critical illness.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients who were treated in the intensive care unit for more than 48 hours at the University Hospital Basel during the specified time frame.
Not a fit: Patients who have documented refusal of general consent or were treated in the intensive care unit for less than 48 hours will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of advance directives, potentially leading to improved patient outcomes and more personalized care in critical situations.
How similar studies have performed: While the specific approach of this study may be novel, previous studies have indicated that advance directives can play a significant role in patient care decisions, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients treated for more than 48 hours in the intensive care unit (post-operative or internal medicine) of the University Hospital Basel in the years 2011-2023 Exclusion Criteria: * Patients with documented refusal of the general consent. * Patients who have been treated in the intensive care unit for less than 48 hours
Where this trial is running
Aarau and 1 other locations
- Kantonsspital Aarau — Aarau, Switzerland (Recruiting)
- Clinic for Intensive Care Medicine, University Hospital Basel — Basel, Switzerland (Recruiting)
Study contacts
- Principal investigator: Raoul Sutter, PD Dr. med — Clinic for Intensive Care Medicine, University Hospital Basel
- Study coordinator: Raoul Sutter, PD Dr. med
- Email: raoul.sutter@usb.ch
- Phone: +41 61 87928
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.